Zhang Yanan, Qiu Jie, Zhang Peng, Zhang Jin, Jiang Min, Ma Zhanbing
Department of Respiratory and Critical Care Medicine, General Hospital of Ningxia Medical University, Ningxia Medical University, Yinchuan, People's Republic of China.
National Engineering Research Center for Beijing Biochip Technology, Sub-center in Ningxia, General Hospital of Ningxia Medical University, Yinchuan, People's Republic of China.
Int J Chron Obstruct Pulmon Dis. 2018 May 25;13:1735-1745. doi: 10.2147/COPD.S162241. eCollection 2018.
Genome-wide association studies identified several genomic regions associated with the risk of chronic obstructive pulmonary disease (COPD), including the 4q22 and 15q25 regions. These regions contain the and genes, which have been associated with COPD but data are lacking for Chinese patients. The objective of the study was to identify new genetic variants in the and associated with COPD in Northwestern China.
This was a case-control study performed in the Ningxia Hui Autonomous Region between January 2014 and December 2016. Patients were grouped as COPD and controls based on FEV/FVC<70%. Seven tag single-nucleotide polymorphisms (SNPs) in the and genes were genotyped using the Agena MassARRAY platform. Logistic regression was used to determine the association between SNPs and COPD risk.
rs17014601 in FAM13A was significantly associated with COPD in the additive (odds ratio [OR]=1.36, 95% confidence interval [CI]: 1.11-1.67, =0.003), heterozygote (OR=1.76, 95% CI: 1.33-2.32, =0.0001), and dominant (OR=1.67, 95% CI: 1.28-2.18, =0.0001) models. Stratified analyses indicated that the risk was higher in never smokers. rs16969858 in IREB2 was significantly associated with COPD but in the univariate analysis only, and the multivariate analysis did not show any association.
The results suggest that the new variant rs17014601 in the gene was significantly associated with COPD risk in a Chinese rural population. Additional studies are required to confirm the role of this variant in COPD development and progression.
全基因组关联研究确定了几个与慢性阻塞性肺疾病(COPD)风险相关的基因组区域,包括4q22和15q25区域。这些区域包含 和 基因,它们与COPD有关,但中国患者的数据尚缺。本研究的目的是在中国西北地区确定 和 基因中与COPD相关的新遗传变异。
这是一项于2014年1月至2016年12月在宁夏回族自治区进行的病例对照研究。根据FEV/FVC<70%将患者分为COPD组和对照组。使用Agena MassARRAY平台对 和 基因中的7个标签单核苷酸多态性(SNP)进行基因分型。采用逻辑回归确定SNP与COPD风险之间的关联。
FAM13A基因中的rs17014601与COPD在加性模型(比值比[OR]=1.36,95%置信区间[CI]:1.11-1.67, =0.003)、杂合子模型(OR=1.76,95%CI:1.33-2.32, =0.0001)和显性模型(OR=1.67,95%CI:1.28-2.18, =0.0001)中显著相关。分层分析表明,从不吸烟者的风险更高。IREB2基因中的rs16969858仅在单变量分析中与COPD显著相关,多变量分析未显示任何关联。
结果表明, 基因中的新变异rs17014601与中国农村人群的COPD风险显著相关。需要进一步研究以证实该变异在COPD发生和发展中的作用。